CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
LY2605541 (LY) exhibits a Flatter Glucodynamic profile than insulin Glargine (GL) at steady state in subjects with Type 1 Diabetes (T1D)
DOI 10.1055/s-0034-1374973
Bibliografische Angaben
Nachweis in CareLit
Autor:innenL Morrow, M Hompesch, S Jacober, SL Choi, Y Qu, V Sinha
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe05/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aim: The aim of this open-label, randomized Phase2 crossover substudy was to investigate the glucodynamic profile of LY, a novel basal insulin analog with prolonged duration of action, compared to GL. Methods: 23 T1D patients underwent 24h Biostator-controlled euglycemic clamps after 8-wks treatment with GL or LY. Clinically titrated basal insulin doses (LY: 16 – 64U, GL: 19 – 60U) were administered the morning of t…
Zitieren
Zitierempfehlung
L Morrow, M Hompesch, S Jacober, SL Choi, Y Qu, V Sinha (2014) LY2605541 (LY) exhibits a Flatter Glucodynamic profile than insulin Glargine (GL) at steady state in subjects with Type 1 Diabetes (T1D). Diabetologie und Stoffwechsel (05). https://doi.org/10.1055/s-0034-1374973
Mit CareLit weiterarbeiten